Ximino

Active Ingredient(s): Minocycline Hydrochloride
FDA Approved: * July 11, 2012
Pharm Company: * RANBAXY LABS LTD
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ximino Overview

Minocycline is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life, it generally has serum levels two to four times that of the simple water-soluble tetracyclines. Minocycline is the most lipid-soluble of the tetracycline-class antibiotics, giving it the greatest penetration into the prostate and brain, but also the greatest amount of cen...

Read more Ximino Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Minocycline

Recent Ximino Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Ximino: (3 results)

Sorted by National Drug Code

• 10631-330 24 Hr Ximino 45 mg Extended Release Capsule by Ranbaxy Laboratories Inc.
• 10631-331 24 Hr Ximino 90 mg Extended Release Capsule by Ranbaxy Laboratories Inc.
• 10631-332 24 Hr Ximino 135 mg Extended Release Capsule by Ranbaxy Laboratories Inc.

Other drugs which contain Minocycline Hydrochloride or a similar ingredient: (7 results)

• ARESTIN Minocycline
• DYNACIN Minocycline
• MINOCIN Minocycline
• MINOCYCLINE 24 discussions
• MINOLIRA Minocycline Hydrochloride
• SOLODYN Minocycline Hydrochloride8 discussions
• VECTRIN Minocycline